{"id":"https://openalex.org/W2152258804","doi":"https://doi.org/10.1001/jama.2015.10017","title":"New Therapies in the Treatment of High Cholesterol","display_name":"New Therapies in the Treatment of High Cholesterol","publication_year":2015,"publication_date":"2015-08-10","ids":{"openalex":"https://openalex.org/W2152258804","doi":"https://doi.org/10.1001/jama.2015.10017","mag":"2152258804","pmid":"https://pubmed.ncbi.nlm.nih.gov/26258765"},"language":"en","primary_location":{"id":"doi:10.1001/jama.2015.10017","doi":"https://doi.org/10.1001/jama.2015.10017","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jama.2015.10017","pdf_url":null,"source":{"id":"https://openalex.org/S172573765","display_name":"JAMA","issn_l":"0002-9955","issn":["0002-9955","0098-7484","1538-3598","2376-8118"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060167116","display_name":"William H. Shrank","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115892","display_name":"CVS Health (United States)","ror":"https://ror.org/02jfw4p72","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115892"]},{"id":"https://openalex.org/I4405272358","display_name":"CVS Health Foundation","ror":"https://ror.org/041z2xr53","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405272358"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William H. Shrank","raw_affiliation_strings":["CVS Health, Woonsocket, Rhode Island"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CVS Health, Woonsocket, Rhode Island","institution_ids":["https://openalex.org/I4210115892","https://openalex.org/I4405272358"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047127868","display_name":"Jane F. Barlow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115892","display_name":"CVS Health (United States)","ror":"https://ror.org/02jfw4p72","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115892"]},{"id":"https://openalex.org/I4405272358","display_name":"CVS Health Foundation","ror":"https://ror.org/041z2xr53","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405272358"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jane F. Barlow","raw_affiliation_strings":["CVS Health, Woonsocket, Rhode Island"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CVS Health, Woonsocket, Rhode Island","institution_ids":["https://openalex.org/I4210115892","https://openalex.org/I4405272358"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103949633","display_name":"Troyen A. Brennan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115892","display_name":"CVS Health (United States)","ror":"https://ror.org/02jfw4p72","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115892"]},{"id":"https://openalex.org/I4405272358","display_name":"CVS Health Foundation","ror":"https://ror.org/041z2xr53","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405272358"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Troyen A. Brennan","raw_affiliation_strings":["CVS Health, Woonsocket, Rhode Island"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CVS Health, Woonsocket, Rhode Island","institution_ids":["https://openalex.org/I4210115892","https://openalex.org/I4405272358"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":8.17,"has_fulltext":false,"cited_by_count":46,"citation_normalized_percentile":{"value":0.98229129,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"314","issue":"14","first_page":"1443","last_page":"1443"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hyperlipidemia","display_name":"hyperlipidemia","score":0.8799999952316284},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.8379999995231628},{"id":"https://openalex.org/keywords/pcsk9-inhibitors","display_name":"PCSK9 inhibitors","score":0.9900000095367432},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.8830000162124634},{"id":"https://openalex.org/keywords/treatment-consensus","display_name":"treatment consensus","score":0.6060000061988831},{"id":"https://openalex.org/keywords/management-strategies","display_name":"management strategies","score":0.46299999952316284}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9645882844924927},{"id":"https://openalex.org/C2778824825","wikidata":"https://www.wikidata.org/wiki/Q7250439","display_name":"Proprotein convertase","level":5,"score":0.9367821216583252},{"id":"https://openalex.org/C2778849439","wikidata":"https://www.wikidata.org/wiki/Q6397985","display_name":"Kexin","level":5,"score":0.9358622431755066},{"id":"https://openalex.org/C2779811187","wikidata":"https://www.wikidata.org/wiki/Q423655","display_name":"Subtilisin","level":3,"score":0.8424632549285889},{"id":"https://openalex.org/C2779091943","wikidata":"https://www.wikidata.org/wiki/Q1079120","display_name":"Hyperlipidemia","level":3,"score":0.6451296806335449},{"id":"https://openalex.org/C2780948078","wikidata":"https://www.wikidata.org/wiki/Q21130010","display_name":"PCSK9","level":5,"score":0.469117671251297},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.4112023115158081},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.4023400545120239},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.34706151485443115},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3376651406288147},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3164586126804352},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.19628220796585083},{"id":"https://openalex.org/C43554185","wikidata":"https://www.wikidata.org/wiki/Q425649","display_name":"LDL receptor","level":4,"score":0.16549652814865112},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.09649944305419922},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06679272651672363},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000071449","descriptor_name":"Proprotein Convertase 9","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005060","descriptor_name":"Europe","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006949","descriptor_name":"Hyperlipidemias","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006949","descriptor_name":"Hyperlipidemias","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D012697","descriptor_name":"Serine Endopeptidases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017410","descriptor_name":"Practice Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D043484","descriptor_name":"Proprotein Convertases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1001/jama.2015.10017","doi":"https://doi.org/10.1001/jama.2015.10017","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jama.2015.10017","pdf_url":null,"source":{"id":"https://openalex.org/S172573765","display_name":"JAMA","issn_l":"0002-9955","issn":["0002-9955","0098-7484","1538-3598","2376-8118"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"journal-article"},{"id":"pmid:26258765","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26258765","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W1520609538","https://openalex.org/W1749910810","https://openalex.org/W2013066189","https://openalex.org/W2019071303","https://openalex.org/W2046181127","https://openalex.org/W2109712320","https://openalex.org/W2118499597","https://openalex.org/W2165624352","https://openalex.org/W4293084779"],"related_works":["https://openalex.org/W3132987709","https://openalex.org/W2563170303","https://openalex.org/W2055915544","https://openalex.org/W2804481703","https://openalex.org/W7154886873","https://openalex.org/W4411023558","https://openalex.org/W2859733068","https://openalex.org/W2588223899","https://openalex.org/W2952363191","https://openalex.org/W3156778682"],"abstract_inverted_index":{"This":[0],"Viewpoint":[1],"discusses":[2],"the":[3,24],"need":[4],"to":[5],"achieve":[6],"consensus":[7],"around":[8],"management":[9],"strategies":[10],"for":[11],"patients":[12],"with":[13],"hyperlipidemia":[14],"when":[15],"proprotein":[16],"convertase":[17],"subtilisin/kexin":[18],"type":[19],"9":[20],"(PCSK-9)":[21],"inhibitors":[22],"enter":[23],"marketplace.":[25]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":17},{"year":2015,"cited_by_count":8}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}